مرکز اطلاعات علمی Scientific Information Database (SID) - Trusted Source for Research and Academic Resources

Persian Verion

مرکز اطلاعات علمی Scientific Information Database (SID) - Trusted Source for Research and Academic Resources

video

مرکز اطلاعات علمی Scientific Information Database (SID) - Trusted Source for Research and Academic Resources

sound

مرکز اطلاعات علمی Scientific Information Database (SID) - Trusted Source for Research and Academic Resources

Persian Version

مرکز اطلاعات علمی Scientific Information Database (SID) - Trusted Source for Research and Academic Resources

View:

770
مرکز اطلاعات علمی Scientific Information Database (SID) - Trusted Source for Research and Academic Resources

Download:

0
مرکز اطلاعات علمی Scientific Information Database (SID) - Trusted Source for Research and Academic Resources

Cites:

1

Information Journal Paper

Title

PREVALENCE OF HYPERPARATHYROIDISM IN PATIENTS WITH THALASSEMIA MAJOR IN IRAN

Pages

  39-48

Abstract

 BACKGROUND AND OBJECTIVE: HYPERPARATHYROIDISM is one the common complications of endocrine in patients with THALASSEMIA MAJOR. Several studies have been conducted to report the prevalence of HYPERPARATHYROIDISM in patients with THALASSEMIA MAJOR in IRAN. However, there is no comprehensive assessment of it. Therefore, the present study was conducted to investigate the prevalence of HYPERPARATHYROIDISM in patients with THALASSEMIA MAJOR in IRAN through SYSTEMATIC REVIEW and META-analysis.METHOD: The present study was conducted based on PRISMA checklist for SYSTEMATIC REVIEW and META-analysis studies. We searched national and international online databases such as Magiran, IRANmedex, SID, Medlib, Scopus, PubMed, Science Direct, Cochrane, Web of Science, Springer, Online library Wiley and Google Scholar for certain standard keywords without time limit until 2016.FINDING: In 19 studies, 3219 patients with THALASSEMIA MAJOR were examined. Prevalence of HYPERPARATHYROIDISM in patients with THALASSEMIA MAJOR in IRAN was calculated to be 10% (CI-95%: 7-10). Moreover, the percentage for various regions of IRAN was different; 14% in the west, 18% in the east, 10% in the north, 12% in the south and 7% in the center of IRAN. Prevalence of HYPERPARATHYROIDISM in men and women was estimated to be 9 and 14, respectively.CONCLUSIONS: Prevalence of HYPERPARATHYROIDISM in patients with THALASSEMIA MAJOR in IRAN is high. Therefore, new policy and planning are necessary to minimize the complications of endocrine glands including HYPERPARATHYROIDISM in patients with THALASSEMIA MAJOR in IRAN

Cites

References

Cite

APA: Copy

AZAMI, M., RAHMATI, SH., & SAYEHMIRI, K.. (2016). PREVALENCE OF HYPERPARATHYROIDISM IN PATIENTS WITH THALASSEMIA MAJOR IN IRAN. JOURNAL OF BABOL UNIVERSITY OF MEDICAL SCIENCES (JBUMS), 18(9), 39-48. SID. https://sid.ir/paper/73488/en

Vancouver: Copy

AZAMI M., RAHMATI SH., SAYEHMIRI K.. PREVALENCE OF HYPERPARATHYROIDISM IN PATIENTS WITH THALASSEMIA MAJOR IN IRAN. JOURNAL OF BABOL UNIVERSITY OF MEDICAL SCIENCES (JBUMS)[Internet]. 2016;18(9):39-48. Available from: https://sid.ir/paper/73488/en

IEEE: Copy

M. AZAMI, SH. RAHMATI, and K. SAYEHMIRI, “PREVALENCE OF HYPERPARATHYROIDISM IN PATIENTS WITH THALASSEMIA MAJOR IN IRAN,” JOURNAL OF BABOL UNIVERSITY OF MEDICAL SCIENCES (JBUMS), vol. 18, no. 9, pp. 39–48, 2016, [Online]. Available: https://sid.ir/paper/73488/en

Related Journal Papers

Related Seminar Papers

  • No record.
  • Related Plans

  • No record.
  • Recommended Workshops






    Move to top
    telegram sharing button
    whatsapp sharing button
    linkedin sharing button
    twitter sharing button
    email sharing button
    email sharing button
    email sharing button
    sharethis sharing button